The Diaphragmatic Initiated Ventilatory Assist (Diva) Trial

The Diaphragmatic Initiated Ventilatory Assist (Diva) Trial

Brief description of study

DIVA is a pragmatic randomized clinical trial (RCT) to determine: among (P) preterm infants born 24-27 6/7 weeks gestation undergoing extubation from mechanical ventilation, whether (I) Non-invasive neurally adjusted ventilatory assist (NIV-NAVA) (C) compared with Non-synchronized nasal intermittent positive pressure ventilation (NS-NIPPV), will reduce the incidence of (O) extubation failure within (T) 5 days (120 hours) of extubation.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Pre-term infants
  • Age: - 99 Years
  • Gender: All

Male and Female, Pre-term babies

Updated on 09 Mar 2024. Study ID: 849912
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For cancer trials contact EmergingMed: 1-855-216-0098 or PennCancerTrials@emergingmend.com

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center